Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

14.67
-0.0900-0.61%
Pre-market: 15.300.6300+4.29%04:10 EDT
Volume:1.04M
Turnover:15.19M
Market Cap:1.52B
PE:-4.81
High:15.01
Open:14.77
Low:14.41
Close:14.76
52wk High:22.50
52wk Low:8.18
Shares:103.41M
Float Shares:86.36M
Volume Ratio:0.80
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0514
EPS(LYR):-3.0514
ROE:-49.63%
ROA:-26.30%
PB:2.82
PE(LYR):-4.81

Loading ...

Leerink Partners Remains a Hold on Nurix Therapeutics (NRIX)

TIPRANKS
·
Oct 10, 2025

Nurix Therapeutics Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Oct 10, 2025

Nurix Therapeutics : Oppenheimer Cuts Target Price to $28 From $30

THOMSON REUTERS
·
Oct 10, 2025

Nurix Therapeutics (NRIX) Gets a Buy from Barclays

TIPRANKS
·
Oct 10, 2025

U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity

Reuters
·
Oct 10, 2025

Nurix Therapeutics Inc reports results for the quarter ended August 31 - Earnings Summary

Reuters
·
Oct 10, 2025

Nurix Therapeutics price target lowered to $28 from $30 at Oppenheimer

TIPRANKS
·
Oct 10, 2025

BRIEF-Nurix Therapeutics Reports Third Quarter 2025 Financial Results And Provides A Corporate Update

Reuters
·
Oct 10, 2025

BUZZ-Nurix Therapeutics falls after Q3 results miss

Reuters
·
Oct 10, 2025

Nurix Therapeutics Shares Fall About 8% to $10 After the Bell Following Results

THOMSON REUTERS
·
Oct 10, 2025

Nurix Therapeutics reports Q3 EPS ($1.03), consensus (85c)

TIPRANKS
·
Oct 10, 2025

Nurix Therapeutics Q3 EPS $(1.03) Misses $(0.88) Estimate, Sales $7.894M Miss $16.736M Estimate

Benzinga
·
Oct 10, 2025

Nurix Therapeutics reports third quarter 2025 revenue of 79 million and net loss of 864 million

Reuters
·
Oct 10, 2025

Nurix Therapeutics Q3 Income From Operations USD -91.385 Million VS. Ibes Estimate USD -78.2 Million

THOMSON REUTERS
·
Oct 10, 2025

Nurix Therapeutics Q3 EPS USD -1.03

THOMSON REUTERS
·
Oct 10, 2025

Nurix Therapeutics Q3 Operating Expenses USD 99.279 Million

THOMSON REUTERS
·
Oct 10, 2025

Nurix Therapeutics Q3 Basic EPS USD -1.03

THOMSON REUTERS
·
Oct 10, 2025

Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire
·
Oct 10, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Oct 07, 2025

Subdued Growth No Barrier To Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Price

Simply Wall St.
·
Sep 30, 2025